Readership
Academics, Allergists, Allied Health Professionals, Biomedical Researchers, Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Educators, Endocrinologists, Epidemiologists, Family Practice Physicians, General Practitioners, Health Scientists, Immunologists, Industrial Hygienists, Industrial Scientists, Infectious Disease Specialists, Internists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Nurses, Obstetricians, Pharmaceutical Benefits Managers, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine, Primary Care Physicians, Researchers, Residents
Scope
npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines, including:
discovery and basic science
nonclinical development of vaccines
biodefense vaccine
AIDS vaccine
vaccine formulation
vaccine adjuvants and conjugate vaccines
cancer/oncology vaccines
clinical evaluation of vaccines
vaccine safety
regulatory science
conventional and non-conventional vaccines
live, attenuated vaccines
inactivated vaccines
subunit vaccines
toxoid vaccines
DNA vaccines
recombinant vector vaccines.
Original research article will include an Editorial Summary that will summarize the key issues being addressed within the article with the goal of keeping the readership informed of advances in the field of vaccinology.
Given the public health importance of vaccines, in addition to publishing high-quality original research, npj Vaccines also publishes commentaries, News and Views (or a similar format), research highlights, editorials, and correspondence from readers, to provide state-of-the-art information for those interested in vaccines.